Compare iShares MSCI Hong Kong ETF (EWH) vs Humana Inc (HUM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI Hong Kong ETF vs Humana Inc — how do they compare? iShares MSCI Hong Kong ETF trades at $22.06 (market cap $1.16B), while Humana Inc trades at $431.03 (market cap $46.49B). The key difference: Humana Inc is far larger — about 40.1× iShares MSCI Hong Kong ETF's market cap, and Humana Inc pays a 0.91% dividend while iShares MSCI Hong Kong ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI Hong Kong ETF for 61 Days and Humana Inc for 51 Days on average.
| EWH | HUM | |
|---|---|---|
Market Cap | $1.16B | $46.49B |
Volume | 3,176,523 | 2,567,704 |
Sector | Broad Market / Factor | Health |
52-Week High | $24.55 | $431.03 |
52-Week Low | $20.66 | $163.67 |
Typical Hold Time | 61 Days | 51 Days |
Enterprise Value | — | $53.84B |
Dividend Yield | — | 0.91% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EWH, the iShares MSCI Hong Kong ETF, trades at $21.72 with a slight 0.65% daily gain amid a predominantly bearish technical backdrop. The ETF's underlying index, the Hang Seng, has faced significant pressure, dropping over 11% from yearly highs due to Federal Reserve policy concerns and US-Iran geopolitical tensions. Technical indicators show bearish moving averages but neutral oscillators, with RSI levels suggesting potential oversold conditions. Recent institutional activity includes Empowered Funds reducing its position by 70.2% in August 2026.
The outlook remains challenged by Hong Kong's market volatility and external pressures, though current levels may attract contrarian interest given the substantial decline from peaks. Key risks include ongoing geopolitical friction, Federal Reserve policy impacts, and China's economic struggles. Upside potential depends on stabilization in Chinese technology stocks and resolution of international tensions.
Humana (HUM) trades at $387.12, down 2.37% today, with a bullish technical outlook supported by moving averages and strong institutional interest. The company shows steady revenue growth reaching $129.7B in 2025, though net margins have compressed to 0.88%. Recent analyst upgrades and a $460.74 consensus price target suggest upside potential, while Medicare Advantage plan changes and fiduciary scrutiny present near-term headwinds.
The stock offers value with a low P/S ratio of 0.32x and consistent earnings beats, but faces margin pressure and regulatory risks. Institutional accumulation and positive technicals support a constructive outlook, though investors should monitor enrollment trends and cost management execution for sustained growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares MSCI Hong Kong ETF
EWH tracks the MSCI Hong Kong 25/50 Index, providing broad exposure to large and mid-cap companies listed in Hong Kong. It focuses on the established pillars of the local economy, with heavy weightings in financials, real estate, and utilities, serving as a single-country diversification tool.
Read more on EWH →About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →
